col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


17 Results       Page 1

 [1] 
New England Journal of Medicine: NEJM Evidence
  original article Date Title Authors   All Authors
1 [GO] 2023―Oct―24 Host Receptor Targeting to Treat Covid-19 Jesper Damsgaard Gunst, Ole Schmeltz Søgaard
2 [GO] 2023―Oct―18 A Randomized Trial of Nafamostat for Covid-19 Susan C. Morpeth, Balasubramanian Venkatesh, James A. Totterdell, Grace M. McPhee, Robert K. Mahar, Mark Jones, et al. (+58)
3 [GO] 2023―Aug―22 The Persistence of SARS-CoV-2 and Its Role in Long Covid Katie E. Lineburg, Corey Smith
4 [GO] 2023―Jul―20 Long-Term Dysfunction of Taste Papillae in SARS-CoV-2 Qin Yao, Máire E. Doyle, Qing-Rong Liu, Ashley Appleton, Jennifer F. O’Connell, Nan-ping Weng, Josephine M. Egan
5 [GO] 2023―Apr―18 Meta-Analysis of Glucocorticoids for Covid-19 Patients Not Receiving Oxygen Remo Daniel Covello, Laura Pasin, Stefano Fresilli, Krisztina Tóth, Caterina Damiani, Ludhmila Abrahão Hajjar, et al. (+2)
6 [GO] 2023―Feb―28 Monitoring Multiple U.S. Government-Supported Covid-19 Vaccine Trials Sally Hunsberger, Susan S. Ellenberg, Steven Joffe, Abdel Babiker, Alan Fix, Marie R. Griffin, et al. (+7)
7 [GO] 2023―Feb―17 Detection of Covid-19 Outbreaks Using Built Environment Testing for SARS-CoV-2 Michael Fralick, Caroline Nott, Jason Moggridge, Lucas Castellani, Ashley Raudanskis, David S. Guttman, et al. (+13)
8 [GO] 2023―Jan―24 The Conundrum of Anticoagulation for Hospitalized Patients with Covid-19 Lauren E. Merz, Annemarie E. Fogerty
9 [GO] 2022―Dec―10 Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19 Zoe K. McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, Jason Roberts, Susan C. Morpeth, James A. Totterdell, et al. (+94)
10 [GO] 2022―Nov―22 Outpatient Randomized Controlled Trials in the Covid-19 Era and Beyond Jean M. Connors, Maria M. Brooks, Frank C. Sciurba, Jerry A. Krishnan, Joseph R. Bledsoe, Lauren Castro, et al. (+13)
11 [GO] 2022―Oct―25 Immune Modulation in Sepsis, ARDS, and Covid-19 - The Road Traveled and the Road Ahead Aleksandra Leligdowicz, Michael O. Harhay, Carolyn S. Calfee, C. Corey Hardin
12 [GO] 2022―Aug―23 What Next? New Drugs, Old Drugs, and New Challenges in Choosing Treatments for Covid-19 Ithan D. Peltan, Samuel M. Brown
13 [GO] 2022―Jul―06 Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis K. Gary Barnette, Michael S. Gordon, Domingo Rodriguez, T. Gary Bird, Alan Skolnick, Michael Schnaus, et al. (+6)
14 [GO] 2021―Dec―22 Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19 José R. Arribas, Sanjay Bhagani, Suzana M. Lobo, Ilsiyar Khaertynova, Lourdes Mateu, Roman Fishchuk, et al. (+14)
15 [GO] 2021―Dec―22 Covid-19 Rates by Time since Vaccination during Delta Variant Predominance Gabriela Paz-Bailey, Maya Sternberg, Kiersten Kugeler, Brooke Hoots, Avnika B. Amin, Amelia G. Johnson, et al. (+39)
16 [GO] 2021―Dec―21 Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults Yoseph Caraco, Gordon E. Crofoot, Pablo Andres Moncada, Anna Nikolaevna Galustyan, Dany Badibanga Musungaie, Brendan Payne, et al. (+13)
17 [GO] 2021―Dec―21 Covid-19 Rates by Time since Vaccination during Delta Variant Predominance Gabriela Paz-Bailey, Maya Sternberg, Kiersten Kugeler, Brooke Hoots, Avnika B. Amin, Amelia G. Johnson, et al. (+39)
 [1] 

17 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec